Addus HomeCare’s Roberton James Stevenson Sells 567 Shares

Addus HomeCare Corporation (NASDAQ: ADUS) announced that its Executive Vice President, Roberton James Stevenson, sold 567 shares of the company’s stock on February 24, 2024. The shares were sold at an average price of $107.35, resulting in a total transaction value of $60,867.45. Following this sale, Stevenson holds 14,314 shares in Addus, amounting to approximately $1,536,607.90. This transaction reflects a 3.81% decline in his ownership stake.

The details of this stock sale were disclosed in a filing with the Securities and Exchange Commission, which is available on their official website. The transaction comes as the company’s stock has been experiencing fluctuations. On the same day, shares of Addus opened at $103.29, marking a decline of 0.7% from previous trading sessions.

Company Performance and Market Analysis

Addus HomeCare has faced a volatile market, with the stock reaching a twelve-month low of $88.96 and a high of $124.43. The company maintains a current ratio of 1.80, a quick ratio of 1.66, and a debt-to-equity ratio of 0.11. With a market capitalization of $1.91 billion, the firm has a price-to-earnings (P/E) ratio of 19.83, a price/earnings to growth (PEG) ratio of 1.49, and a beta of 0.91. The 50-day moving average stands at $109.41, while the 200-day moving average is $113.01.

Investment analysts have expressed varied opinions regarding Addus HomeCare’s future performance. In a recent report, BMO Capital Markets initiated coverage of the company, assigning a “market perform” rating with a price target of $120.00. Conversely, Stephens adjusted their price target from $140.00 to $135.00, maintaining an “overweight” rating. Barclays also revised their price objective from $117.00 to $112.00, labeling the stock as “underweight.”

MarketBeat data indicates that analysts have differing views on Addus HomeCare’s stock, with one analyst rating it as a Strong Buy, seven as Buy, two as Hold, and one as Sell. The consensus rating for the stock is “Moderate Buy,” with a target price averaging $134.33.

About Addus HomeCare

Addus HomeCare is a prominent provider of home and community-based care services in the United States, catering to elderly, disabled, and medically complex individuals. The company operates through a network of both company-owned and franchise locations, offering a wide range of non-medical personal care and licensed home health services. These services are designed to promote independence and enhance the quality of life for clients.

Core offerings include personal care assistance, which encompasses daily living activities, medication reminders, and light housekeeping, in addition to skilled home health services provided under the supervision of registered nurses and licensed therapists.

Recent developments and ongoing analysis continue to shape the landscape for Addus HomeCare as they navigate the challenges and opportunities within the healthcare sector.